^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    prednisolone

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    GCR agonist
    Related drugs:
    Associations

    News

    Trials
    8d
    VEXAS syndrome with eosinophilia and pathologically mimicking histiocytosis: A case report. (PubMed, Mod Rheumatol Case Rep)
    The patient responded favourably to the oral prednisolone therapy...Clinicians should be aware of these potential atypical manifestations to prevent delays in the diagnosis and treatment of VEXAS syndrome. Further research is warranted to delineate the full spectrum of clinical and pathological presentations of VEXAS.
    Journal
    |
    CD68 (CD68 Molecule)
    |
    prednisolone
    11d
    Intravenous Immunoglobulin and Prednisolone for RPL After ART. (clinicaltrials.gov)
    P2, N=80, Completed, Aalborg University Hospital | Recruiting --> Completed
    Trial completion
    |
    prednisolone
    15d
    EDSAMS: ED-Initiated School-based Asthma Medication Supervision (clinicaltrials.gov)
    P4, N=13, Completed, University of Arizona | N=90 --> 13
    Enrollment change
    |
    prednisolone
    16d
    The Effect of Three Different Medications on Anesthetic Success and Postoperative Pain (clinicaltrials.gov)
    P=N/A, N=120, Recruiting, Cairo University | Trial completion date: Oct 2025 --> Jan 2026 | Trial primary completion date: Aug 2025 --> Dec 2025 | Trial primary completion date: Aug 2025 --> Dec 2025
    Trial completion date • Trial primary completion date
    |
    prednisolone
    1m
    Adalimumab in refractory pediatric tubulointerstitial nephritis and uveitis syndrome: a case report of sustained renal-ocular remission and literature review. (PubMed, BMC Nephrol)
    Adalimumab can effectively control inflammatory responses and reduce recurrence in pediatric TINU syndrome, with a favorable safety profile, thereby providing a novel and promising biologic alternative for steroid-resistant or refractory cases. It is recommended to focus on ocular lesions in patients with tubulointerstitial injuries to avoid missing the diagnosis of TINU syndrome.
    Journal
    |
    TNFA (Tumor Necrosis Factor-Alpha)
    |
    prednisolone
    1m
    STAR: STeroids in preschool Asthma Reduction study: A double-blinded non-inferiority randomised controlled trial of n1- versus 3-days of oral prednisolone for preschool children with moderate to severe exacerbations of asthma/wheeze (ACTRN12625001112459)
    P3, N=1074, Not yet recruiting, Te Whatu Ora Health New Zealand Te Toka Tumai Auckland - Starship Children's Hospital
    New P3 trial • Head-to-Head
    |
    prednisolone
    2ms
    MORAb-202-G000-201: A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types (clinicaltrials.gov)
    P1/2, N=182, Recruiting, Eisai Inc. | Trial completion date: Dec 2024 --> Aug 2030 | Trial primary completion date: Dec 2024 --> Aug 2030
    Trial completion date • Trial primary completion date
    |
    HER-2 (Human epidermal growth factor receptor 2) • BRAF (B-raf proto-oncogene) • ER (Estrogen receptor) • ALK (Anaplastic lymphoma kinase) • PGR (Progesterone receptor) • ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS)
    |
    HER-2 negative
    |
    Lenvima (lenvatinib) • prednisone • farletuzumab ecteribulin (MORAb-202) • prednisolone
    2ms
    RUBY: "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" (clinicaltrials.gov)
    P3, N=120, Not yet recruiting, Assistance Publique - Hôpitaux de Paris
    New P3 trial
    |
    prednisolone
    2ms
    Pembrolizumab-Induced Chronic Rhinosinusitis in a Patient With Non-Small Cell Lung Cancer. (PubMed, Respirol Case Rep)
    The patient was diagnosed with immune-related chronic rhinosinusitis and treated with oral prednisolone after discontinuation of pembrolizumab. Herein, we report a rare case of pembrolizumab-induced chronic rhinosinusitis without nasal polyps that was successfully treated with oral corticosteroid therapy.
    Journal
    |
    CD20 (Membrane Spanning 4-Domains A1) • CD8 (cluster of differentiation 8) • KRT19 (Keratin 19) • CRP (C-reactive protein)
    |
    Keytruda (pembrolizumab) • prednisolone
    3ms
    MMFPRIMER: Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy (clinicaltrials.gov)
    P3, N=43, Completed, Kyungpook National University Hospital | Unknown status --> Completed | N=62 --> 43
    Trial completion • Enrollment change
    |
    prednisolone
    4ms
    A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma (clinicaltrials.gov)
    P1/2, N=97, Recruiting, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
    New P1/2 trial
    |
    gemcitabine • doxorubicin hydrochloride • cyclophosphamide • oxaliplatin • prednisone • prednisolone
    4ms
    M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) (clinicaltrials.gov)
    P1, N=141, Recruiting, EMD Serono Research & Development Institute, Inc. | N=96 --> 141 | Trial completion date: Mar 2026 --> Feb 2027 | Trial primary completion date: Mar 2026 --> Feb 2027
    Enrollment change • Trial completion date • Trial primary completion date
    |
    abiraterone acetate • prednisone • tuvusertib (M1774) • M9466 • prednisolone